Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daré Bioscience
Biotech
FDA delays force Daré to shelve phase 3 plans: WSJ
In the last two months, the FDA has pushed back the date it would provide guidance twice, according to Daré's CEO.
Gabrielle Masson
Apr 17, 2025 3:03pm
Women in biotech see Roe v. Wade ruling as a call to action
Jul 11, 2022 8:00am
Biotech's women leaders decry abortion bans
Jul 5, 2022 10:52am
Women at BIO say 'I'm here to do my job' despite toxic tropes
Jun 16, 2022 8:32am
Daré nabs implant tech
Nov 15, 2019 9:30am
BIO: In conversation with Sabrina Johnson, CEO of Daré Bioscience
Jun 5, 2019 8:55am
